INBS logo

INBS

Profile

Full Name

Intelligent Bio Solutions Inc.

Ticker Symbol

INBS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 23, 2020

Indexes

Not included

Website

http://ibs.inc

Employees

50

Key Details

Price

$1.19(-0.83%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.11M(+147.58% YoY)

Annual EPS

-$6.38(+94.98% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.19
INBS price is $1.19

30-Day Relative Volume

0.21
INBS 30-day relative volume is 0.21

Price Performance

Price Most recent change

-0.83%
INBS price was down -0.83% on Apr 17, 2025

Price YTD change

-15%
INBS price is down -15% since January 1st

Price 1-year change

-55.6%
INBS price is down -55.6% year-on-year

Price 3-year change

-99.46%
INBS price is down -99.46% over the past 3 years

Price Range

Price All-time high

$3417.60
INBS price is currently -99.97% below its historical high of $3417.60

Price 3-year low

$1.00
INBS price is currently +19.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.28M
INBS market capitalization is $6.28 million

Market cap 3-year change

-53.61%
INBS market capitalization is down -53.61% over the past 3 years

Market cap All-time high

$124.31M
INBS market capitalization is currently -94.95% below its historical high of $124.31 million

Market cap sector rank

15.31%
INBS market capitalization is higher than 15.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+81.17%
INBS shares outstanding is up +81.17% year-on-year

Shares Outstanding 3-Year Change

+8414.19%
INBS shares outstanding is up +8414.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.05
INBS beta is 1.05

200-day SMA

$1.62
INBS price is currently -26.62% below its 200-day simple moving average

50-day SMA

$1.90
INBS price is currently -37.44% below its 50-day simple moving average

RSI

29.36
INBS 14-day relative strength index is 29.36

Volume

0.21
INBS 30-day relative volume is 0.21

ATR

$0.14
INBS average true range is $0.14

10-day Historical Volatility

85.92%
INBS 10-day historical volatility is 85.92%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.11M
INBS annual revenue is $3.11 million

Revenue Analysts estimate

$11.62M
INBS annual revenue is currently -73.22% lower than the consensus analysts' forecast

Revenue 1-year change

+147.58%
INBS annual revenue is up +147.58% year-on-year

Revenue Sector rank

18.5%
INBS annual revenue is higher than 18.5% of companies in Healthcare sector

EPS

EPS

-$6.38
INBS annual earnings per share is -$6.38

EPS Analysts estimate

-$1.25
INBS annual earnings per share is currently +410.40% higher than the consensus analysts' forecast

EPS 1-year change

+94.98%
INBS annual earnings per share is up +94.98% year-on-year

EPS Sector rank

15.99%
INBS annual earnings per share is higher than 15.99% of companies in Healthcare sector

Profit

Gross profit

$1.43M
INBS annual gross profit is $1.43 million

Gross margin

45.81%
INBS annual gross profit margin is 45.81%

Operating profit

-$10.28M
INBS annual operating income is -$10.28 million

Operating margin

-330.46%
INBS annual operating profit margin is -330.46%

Net income

-$10.16M
INBS annual net profit is -$10.16 million

Net margin

-326.40%
INBS annual net profit margin is -326.40%

Expenses

Total expenses

$13.39M
INBS annual total expenses is $13.39 million

Operating expenses

$11.71M
INBS annual total operating expenses is $11.71 million

Cost of goods sold

$1.69M
INBS annual cost of goods sold is $1.69 million

Selling, general & administrative expenses

$9.26M
INBS annual SGA is $9.26 million

Depreciation and amortization

$1.21M
INBS annual depreciation & amortization is $1.21 million

Interest expense

$167.10K
INBS annual interest expense is $167.10 thousand

Income tax

-
INBS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$10.02M
INBS annual earnings before interest & taxes is -$10.02 million

EBITDA

-$8.81M
INBS annual EBITDA is -$8.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.78M
INBS annual total assets is $13.78 million

Non current assets

$5.24M
INBS annual long term assets is $5.24 million

Current assets

$8.53M
INBS annual total current assets is $8.53 million

Cash and cash equivalents

$6.30M
INBS annual cash & cash equivalents is $6.30 million

Accounts receivable

$429.70K
INBS annual accounts receivable is $429.70 thousand

Inventory

$777.50K
INBS annual inventory is $777.50 thousand

Liabilities

Total liabilities

$5.60M
INBS annual total liabilities is $5.60 million

Long term liabilities

$144.90K
INBS annual total long term liabilities is $144.90 thousand

Current liabilities

$5.45M
INBS annual total current liabilities is $5.45 million

Accounts payable

$602.30K
INBS annual accounts payable is $602.30 thousand

Debt

Total debt

$871.40K
INBS annual total debt is $871.40 thousand

Total debt 1-year change

-34.76%
INBS annual total debt is down -34.76% year-on-year

Long term debt

$81.30K
INBS annual long term debt is $81.30 thousand

Short term debt

$790.10K
INBS annual short term debt is $790.10 thousand

Equity & Capital

Shareholders equity

$8.33M
INBS annual stockholders equity is $8.33 million

Book value

$8.33M
INBS annual book value is $8.33 million

Retained earnings

-$51.96M
INBS annual retained earnings is -$51.96 million

Working capital

$3.08M
INBS annual working capital is $3.08 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.57M
INBS annual cash flow from operations is -$9.57 million

Cash from operations 1-year change

-29.74%
INBS annual cash flow from operations is down -29.74% year-on-year

Cash from investing

-$221.40K
INBS annual cash flow from investing activities is -$221.40 thousand

Cash from investing 1-year change

+68.1%
INBS annual cash flow from investing activities is up +68.1% year-on-year

Cash from financing

$14.56M
INBS annual cash flow from financing activities is $14.56 million

Cash from financing 1-year change

+914.46%
INBS annual cash flow from financing activities is up +914.46% year-on-year

CAPEX

CAPEX

$221.40K
INBS annual capital expenditures is $221.40 thousand

CAPEX 1-year change

-56.17%
INBS annual capital expenditures is down -56.17% year-on-year

Free Cash Flow

Free cash flow

-$9.79M
INBS annual free cash flow is -$9.79 million

Free cash flow 1-year change

-24.24%
INBS annual free cash flow is down -24.24% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.81%
INBS annual gross profit margin is 45.81%

Operating margin

-330.46%
INBS annual operating profit margin is -330.46%

Net margin

-326.40%
INBS annual net profit margin is -326.40%

ROA & ROE

ROA

-84.17%
INBS annual return on assets is -84.17%

ROE

-171.13%
INBS annual return on equity is -171.13%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INBS price to earnings ratio value is unknown

PE ratio Sector rank

-
INBS price to earnings ratio is unknown

PB Ratio

PB ratio

1.44
INBS price to book ratio is 1.44

PB ratio Sector rank

54.41%
INBS price to book ratio is higher than 54.41% of companies in Healthcare sector

PS Ratio

PS ratio

2.07
INBS price to sales ratio is 2.07

PS ratio Sector rank

44.03%
INBS price to sales ratio is higher than 44.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.67M
INBS enterprise value is $4.67 million

Enterprise value Sector rank

18.93%
INBS enterprise value is higher than 18.93% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.50
INBS EV/EBITDA is -0.50

EV/EBITDA Sector rank

51.7%
INBS EV/EBITDA is higher than 51.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.57
INBS annual current ratio is 1.57

Quick ratio

1.42
INBS annual quick ratio is 1.42

Leverage

Debt to equity

0.06
INBS annual debt to equity ratio is 0.06

Interest coverage ratio

-59.99
INBS annual interest coverage ratio is -59.99

Risk & Stability

Piotroski F-Score

4
INBS piotroski f-score is 4

Altman Z-Score

-6.51
INBS altman z-score is -6.51

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Ridgetech (RDGT)
CJJD logo
China Jo-Jo Drugstores (CJJD)
AYTU logo
Aytu BioPharma (AYTU)
Mobile-health Network Solutions Class A (MNDR)
MOVE logo
Movano (MOVE)
WORK Medical Technology Group LTD (WOK)
MetaVia (MTVA)
SSY logo
SunLink Health Systems (SSY)
LIPO logo
Lipella Pharmaceuticals (LIPO)
  • What is the ticker symbol for Intelligent Bio Solutions?
  • Does Intelligent Bio Solutions pay dividends?
  • What sector is Intelligent Bio Solutions in?
  • What industry is Intelligent Bio Solutions in?
  • What country is Intelligent Bio Solutions based in?
  • When did Intelligent Bio Solutions go public?
  • Is Intelligent Bio Solutions in the S&P 500?
  • Is Intelligent Bio Solutions in the NASDAQ 100?
  • Is Intelligent Bio Solutions in the Dow Jones?
  • When was Intelligent Bio Solutions's last earnings report?
  • When does Intelligent Bio Solutions report earnings?
  • Should I buy Intelligent Bio Solutions stock now?

What is the ticker symbol for Intelligent Bio Solutions?

The ticker symbol for Intelligent Bio Solutions is NASDAQ:INBS

Does Intelligent Bio Solutions pay dividends?

No, Intelligent Bio Solutions does not pay dividends

What sector is Intelligent Bio Solutions in?

Intelligent Bio Solutions is in the Healthcare sector

What industry is Intelligent Bio Solutions in?

Intelligent Bio Solutions is in the Medical Devices industry

What country is Intelligent Bio Solutions based in?

Intelligent Bio Solutions is headquartered in United States

When did Intelligent Bio Solutions go public?

Intelligent Bio Solutions's initial public offering (IPO) was on December 23, 2020

Is Intelligent Bio Solutions in the S&P 500?

No, Intelligent Bio Solutions is not included in the S&P 500 index

Is Intelligent Bio Solutions in the NASDAQ 100?

No, Intelligent Bio Solutions is not included in the NASDAQ 100 index

Is Intelligent Bio Solutions in the Dow Jones?

No, Intelligent Bio Solutions is not included in the Dow Jones index

When was Intelligent Bio Solutions's last earnings report?

Intelligent Bio Solutions's most recent earnings report was on Feb 13, 2025

When does Intelligent Bio Solutions report earnings?

The next expected earnings date for Intelligent Bio Solutions is May 8, 2025

Should I buy Intelligent Bio Solutions stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page